BC-CfE Guidelines for the use of Paxlovid® and ARVs

By

Safety considerations for nirmatrelvir/ritonavir (Paxlovid¨) use in persons living with HIV whether or not on antiretroviral treatment, or persons at risk of HIV while on PrEP who are diagnosed with COVID-19 infection The COVID-19 therapy Paxlovid¨ consists of the antiviral medication nirmatrelvir co-packaged with the pharmacokinetic enhancer (“booster”) ritonavir, taken as a twice daily, oral, […]

BC-CfE Guidelines for the use of Paxlovid® and ARVs Read More »